Allogene Therapeutics Inc

$2.00
Market Cap 487.56M
ROE -56.4%
Gross Margin 0.0%
Debt/Equity 0.0
Current Ratio 9.6
Revenue QoQ 0.0%
EPS QoQ -0.4%
F-Score 3

About

Allogene Therapeutics Inc - Ordinary Shares

Exchange
NASDAQ
Sector
Healthcare
Industry
Biotechnology

Sector context

Healthcare

Undervalued

Trading at a discount to sector peers

P/E
-2.67
vs median 32.28
P/B
1.66
vs median 2.77
ROE
-0.56
vs median 0.12

Lower quality - review fundamentals carefully

Small-cap company with higher volatility

Similar companies

VALNNGNEEIKNDRUGFDMTSTRO
Primary metric
Overlay metric
Loading chart data...
Fetching latest financial metrics